You are here

  • Home
  • Archive
  • Volume 80, Issue 10
  • SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity

Citation Tools

Article menu
Download PDFPDF
Epidemiology
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mrak D, Tobudic S, Koblischke M, et al
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
Annals of the Rheumatic Diseases 2021;80:1345-1350.